Funding Opportunities and Deadlines

Research Priority

Immunotherapies

Letter of Intent Due

August 05

Therapeutic Development and Clinical Testing of Immune Therapies for Type 1 Diabetes

Details

Milestone Date Status
Letter of Intent Aug 05, 2019 Next
Application Oct 31, 2019
Award Notification Mar 31, 2020
Earliest Start May 01, 2020
Immunotherapies

Letter of Intent Due

August 01

Validation of T Cell Biomarkers and Assays for T1D

Details

Milestone Date Status
Letter of Intent Aug 01, 2019 Next
Application Oct 01, 2019
Award Notification Feb 28, 2020
Earliest Start Apr 01, 2020
Immunotherapies

Letter of Intent Due

September 09

Decoding Immune Mediated Diseases – Novel Approaches for Therapeutic Insights

Details

Milestone Date Status
Letter of Intent Sep 09, 2019 Next
Application Dec 03, 2019
Award Notification May 31, 2020
Earliest Start Aug 01, 2020
Mission

Application Due

August 28

JDRF National Diabetes Psychology Fellowship Program: 2020 Host Site Application

Details

Milestone Date Status
Letter of Intent N/A
Application Aug 28, 2019 Next
Award Notification Sep 27, 2019
Earliest Start Oct 01, 2019
Prevention

Application Due
(Letter of Intent Required)

July 02

Neoepitopes in Type 1 Diabetes: Pathogenesis, Staging, and Therapeutic Utility

Details

Milestone Date Status
Letter of Intent Required May 16, 2019 Passed
Application Jul 02, 2019 Next
Award Notification Nov 30, 2019
Earliest Start Jan 01, 2020

Ongoing Opportunities

These funding sources are typically available annually or ongoing

Conference Grants

Industry Discovery & Development Partnerships

Early-Career Patient-Oriented Diabetes Research Awards (projects in COMPLICATIONS are ineligible)
Jul 02

Career Development Awards (projects in COMPLICATIONS are ineligible)
Jul 02

Advanced Postdoctoral Fellowships (projects in COMPLICATIONS are ineligible)
Jul 02

Postdoctoral Fellowships (projects in COMPLICATIONS are ineligible)
Jul 02

Project Concepts (Strategic Research Agreement)
Aug 01

JDRF Impact Grants
Sep 16

RFAs Awaiting Notification

Jul

Novel Pathways and Targets for Beta Cell Regenerating Therapies in Diabetes
Jul

Pilot Studies for Mechanisms of T1D Disease Pathogenesis
Jul

Innovative Strategies To Demonstrate “Immunological Proof-of-Mechanism” And To Explore Early Outcome Measures In Immunotherapy Trials
Jul

Therapeutic Development and Early Clinical Testing of T Cell Targeted Immunotherapies for the Treatment of Type 1 Diabetes
Aug

JDRF National Diabetes Psychology Fellowship Program
Aug

No (Type) One Left Behind: Expanding Artificial Pancreas Adoption and Access Among Targeted Populations